NR4A1 and breast carcinoma: Similar results were observed in RKO and SW480 cells (Fig. 2F), indicating that PD-L1 is regulated by NR4A1/Sp1 in colon cancer cells as previously observed in human and mouse breast cancer cells [23] and NR4A1 antagonists decrease expression of this checkpoint gene product.